All guides
Canada budget/Canada
Health Canada medical device licence: cost and timeline 2026
A founder guide to Health Canada Medical Device Licence planning, cost categories, timeline questions, and evidence preparation.
Direct answer
Health Canada timing and cost depend on device class, evidence readiness, quality system status, application quality, and whether the product or company activity also creates establishment-licence questions. Do not reduce the plan to one government fee.
The useful planning package separates government fees, consultant time, testing or evidence work, quality system work, distributor readiness, and launch assumptions.
Use this if
Reader
A founder or operator budgeting Canada market entry
Trigger
The team is comparing Canada entry with United States entry or distributor timing
Blocked decision
Whether Canada launch budget and evidence preparation are realistic
Useful output
A planning checklist for licence, evidence, consultant, and commercial timing questions
Do these first
- Confirm device class and whether product-level licensing is in scope.
- Check whether importer, distributor, or manufacturer activity creates MDEL questions.
- Map government fees separately from consultant and evidence costs.
- Prepare a Canada-specific source ledger before making launch promises.
What to collect before you ask for help
- Device class and intended use.
- Existing foreign approvals, licences, or clearances.
- Quality system evidence and manufacturer role.
- Canada importer, distributor, and sales-channel plan.
Common mistakes
- Budgeting only the government fee.
- Ignoring MDEL questions while focusing on MDL.
- Assuming FDA evidence transfers without Canada-specific review.
Public sources to start with